| Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure L Golden-Mason, L Madrigal-Estebas, E McGrath, MJ Conroy, EJ Ryan, ... Gut 57 (8), 1121-1128, 2008 | 174 | 2008 |
| Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment MB Mockler, MJ Conroy, J Lysaght Frontiers in oncology 4, 107, 2014 | 93 | 2014 |
| CX3CL1 signaling in the tumor microenvironment MJ Conroy, J Lysaght Tumor microenvironment: the role of chemokines–part A, 1-12, 2020 | 72 | 2020 |
| Mucosal-associated invariant T cells display diminished effector capacity in oesophageal adenocarcinoma AM Melo, AM O'Brien, JJ Phelan, SA Kennedy, NAW Wood, N Veerapen, ... Frontiers in immunology 10, 1580, 2019 | 58 | 2019 |
| Impact of the inflammatory microenvironment on T-cell phenotype in the progression from reflux oesophagitis to Barrett oesophagus and oesophageal adenocarcinoma ME Kavanagh, MJ Conroy, NE Clarke, NT Gilmartin, KE O'Sullivan, ... Cancer letters 370 (1), 117-124, 2016 | 55 | 2016 |
| Human dorsal root ganglion pulsed radiofrequency treatment modulates cerebrospinal fluid lymphocytes and neuroinflammatory markers in chronic radicular pain B Das, M Conroy, D Moore, J Lysaght, C McCrory Brain, behavior, and immunity 70, 157-165, 2018 | 46 | 2018 |
| Obesity-associated cancer: an immunological perspective MJ Conroy, MR Dunne, CL Donohoe, JV Reynolds Proceedings of the Nutrition Society 75 (2), 125-138, 2016 | 44 | 2016 |
| Identifying a Novel Role for Fractalkine (CX3CL1) in Memory CD8+ T Cell Accumulation in the Omentum of Obesity-Associated Cancer Patients MJ Conroy, SG Maher, AM Melo, SL Doyle, E Foley, JV Reynolds, A Long, ... Frontiers in Immunology 9, 1867, 2018 | 39 | 2018 |
| CCR1 antagonism attenuates T cell trafficking to omentum and liver in obesity‐associated cancer MJ Conroy, KC Galvin, ME Kavanagh, AM Mongan, SL Doyle, N Gilmartin, ... Immunology and Cell Biology 94 (6), 531-537, 2016 | 31 | 2016 |
| Altered T cell migratory capacity in the progression from barrett oesophagus to oesophageal adenocarcinoma ME Kavanagh, MJ Conroy, NE Clarke, NT Gilmartin, R Feighery, ... Cancer Microenvironment 12, 57-66, 2019 | 25 | 2019 |
| The microenvironment of visceral adipose tissue and liver alter natural killer cell viability and function MJ Conroy, V Fitzgerald, SL Doyle, S Channon, Z Useckaite, N Gilmartin, ... Journal of Leucocyte Biology 100 (6), 1435-1442, 2016 | 22 | 2016 |
| Harnessing natural killer cells in non-small cell lung cancer É Russell, MJ Conroy, MP Barr Cells 11 (4), 605, 2022 | 21 | 2022 |
| Existing evidence for the repurposing of PARP-1 inhibitors in rare demyelinating diseases M Mekhaeil, KK Dev, MJ Conroy Cancers 14 (3), 687, 2022 | 21 | 2022 |
| A study of the immune infiltrate and patient outcomes in esophageal cancer MJ Conroy, SA Kennedy, SL Doyle, B Hayes, M Kavanagh, ... Carcinogenesis 42 (3), 395-404, 2021 | 21 | 2021 |
| Increased Frequencies of Circulating IFN-γ-Producing Vδ1+ and Vδ2+ γδ T Cells in Patients with Asymptomatic Persistent Hepatitis B Virus Infection MJ Conroy, R Mac Nicholas, M Taylor, S O'Dea, F Mulcahy, S Norris, ... Viral Immunology 28 (4), 201-208, 2015 | 20 | 2015 |
| Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon‐γ or interleukin‐10 are expanded in asymptomatic, E antigen‐negative patients … MJ Conroy, R Mac Nicholas, R Grealy, M Taylor, JA Otegbayo, S O'Dea, ... Journal of viral hepatitis 22 (3), 335-345, 2015 | 20 | 2015 |
| Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients M Davern, NE Donlon, F O’Connell, C Gaughan, C O’Donovan, ... Cancer Immunology, Immunotherapy 72 (1), 55-71, 2023 | 19 | 2023 |
| Natural killer cell therapy: A new frontier for obesity-associated cancer E Mylod, J Lysaght, MJ Conroy Cancer Letters 535, 215620, 2022 | 19 | 2022 |
| Parallel profiles of inflammatory and effector memory T cells in visceral fat and liver of obesity-associated cancer patients MJ Conroy, KC Galvin, SL Doyle, ME Kavanagh, AM Mongan, A Cannon, ... Inflammation 39, 1729-1736, 2016 | 19 | 2016 |
| Examination and characterisation of burst spinal cord stimulation on cerebrospinal fluid cellular and protein constituents in patient responders with chronic neuropathic pain-A … J Royds, MJ Conroy, MR Dunne, H Cassidy, D Matallanas, J Lysaght, ... Journal of Neuroimmunology 344, 577249, 2020 | 18 | 2020 |